|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Murali R, Soslow RA and Weigelt B:
Classification of endometrial carcinoma: More than two types.
Lancet Oncol. 15:e268–e278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bokhman JV: Two pathogenetic types of
endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Polakis P: Wnt signaling in cancer. Cold
Spring Harbor perspectives in biology. 4:pii:a0080522012.
View Article : Google Scholar
|
|
6
|
Taniguchi H, Yamamoto H, Hirata T,
Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai KA and Shinomura
Y: Frequent epigenetic inactivation of Wnt inhibitory factor-1 in
human gastrointestinal cancers. Oncogene. 24:7946–7952. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yoshino M, Suzuki M, Tian L, Moriya Y,
Hoshino H, Okamoto T, Yoshida S, Shibuya K and Yoshino I: Promoter
hypermethylation of the p16 and Wif-1 genes as an independent
prognostic marker in stage IA non-small cell lung cancers. Int J
Oncol. 35:1201–1209. 2009.PubMed/NCBI
|
|
8
|
Urakami S, Shiina H, Enokida H, Kawakami
T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA,
Terashima M, et al: Epigenetic inactivation of Wnt inhibitory
factor-1 plays an important role in bladder cancer through aberrant
canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res.
12:383–391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Patel L, Mills GB, Lu KH, Sood AK,
Ding L, Kucherlapati R, Mardis ER, Levine DA, Shmulevich I, et al:
Clinical significance of CTNNB1 mutation and Wnt pathway activation
in endometrioid endometrial carcinoma. J Natl Cancer Inst.
106:pii:dju2452014. View Article : Google Scholar
|
|
10
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huelsken J, Vogel R, Erdmann B, Cotsarelis
G and Birchmeier W: Beta-catenin controls hair follicle
morphogenesis and stem cell differentiation in the skin. Cell.
105:533–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Weigelt B and Banerjee S: Molecular
targets and targeted therapeutics in endometrial cancer. Curr Opin
Oncol. 24:554–563. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klaus A and Birchmeier W: Wnt signalling
and its impact on development and cancer. Nat Rev Cancer.
8:387–398. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dedes KJ, Wetterskog D, Ashworth A, Kaye
SB and Reis-Filho JS: Emerging therapeutic targets in endometrial
cancer. Nat Rev Clin Oncol. 8:261–271. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Matias-Guiu X and Prat J: Molecular
pathology of endometrial carcinoma. Histopathology. 62:111–123.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
McConechy MK, Ding J, Cheang MC, Wiegand
K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T, et al: Use of
mutation profiles to refine the classification of endometrial
carcinomas. J Pathol. 228:20–30. 2012.PubMed/NCBI
|
|
17
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signalling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tamai K, Semenov M, Kato Y, Spokony R, Liu
C, Katsuyama Y, Hess F, Saint-Jeannet JP and He X:
LDL-receptor-related proteins in Wnt signal transduction. Nature.
407:530–535. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yee DS, Tang Y, Li X, Liu Z, Guo Y,
Ghaffar S, McQueen P, Atreya D, Xie J, Simoneau AR, et al: The Wnt
inhibitory factor 1 restoration in prostate cancer cells was
associated with reduced tumor growth, decreased capacity of cell
migration and invasion and a reversal of epithelial to mesenchymal
transition. Mol Cancer. 9:1622010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramachandran I, Thavathiru E, Ramalingam
S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A,
Anant S and Queimado L: Wnt inhibitory factor 1 induces apoptosis
and inhibits cervical cancer growth, invasion and angiogenesis in
vivo. Oncogene. 31:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang SH, Li SL, Dong ZM and Kan QC:
Epigenetic inactivation of Wnt inhibitory factor-1 in human
esophageal squamous cell carcinoma. Oncol Res. 20:123–130. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kawakami K, Hirata H, Yamamura S, Kikuno
N, Saini S, Majid S, Tanaka Y, Kawamoto K, Enokida H, Nakagawa M
and Dahiya R: Functional significance of Wnt inhibitory factor-1
gene in kidney cancer. Cancer Res. 69:8603–8610. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kansara M, Tsang M, Kodjabachian L, Sims
NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons
PJ, et al: Wnt inhibitory factor 1 is epigenetically silenced in
human osteosarcoma, and targeted disruption accelerates
osteosarcomagenesis in mice. J Clin Invest. 119:837–851. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malinauskas T, Aricescu AR, Lu W, Siebold
C and Jones EY: Modular mechanism of Wnt signaling inhibition by
Wnt inhibitory factor 1. Nat Struct Mol Biol. 18:886–893. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang L, Li MX, Wang L, Li BK, Chen GH, He
LR, Xu L and Yuan YF: Prognostic value of Wnt inhibitory factor-1
expression in hepatocellular carcinoma that is independent of gene
methylation. Tumour Biol. 32:233–240. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoshino M, Suzuki M, Tian L, Moriya Y,
Hoshino H, Okamoto T, Yoshida S, Shibuya K and Yoshino I: Promoter
hypermethylation of the p16 and Wif-1 genes as an independent
prognostic marker in stage IA non-small cell lung cancers. Int J
Oncol. 35:1201–1209. 2009.PubMed/NCBI
|
|
27
|
Kim SA, Kwak J, Nam HY, Chun SM, Lee BW,
Lee HJ, Khang SK and Kim SW: Promoter methylation of WNT inhibitory
factor-1 and expression pattern of WNT/β-catenin pathway in human
astrocytoma: Pathologic and prognostic correlations. Mod Pathol.
26:626–639. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Zhou B, Liu Y, Chen K, Bao P,
Wang Y, Wang J, Zhou Z, Sun X and Li Y: Wnt inhibitory factor-1
functions as a tumor suppressor through modulating Wnt/β-catenin
signaling in neuroblastoma. Cancer Lett. 348:12–19. 2014.
View Article : Google Scholar : PubMed/NCBI
|
